|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240.40 USD | +0.32% |
|
-3.23% | +16.16% |
| 03-06 | Johnson & Johnson Units to Pay $65 Million to Settle Tracleer Antitrust Lawsuit | MT |
| 03-06 | Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment | MT |
| Capitalization | 579B 500B 451B 433B 789B 53,241B 826B 5,330B 2,136B 25,532B 2,174B 2,128B 91,314B | P/E ratio 2026 * |
24.5x | P/E ratio 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise value | 597B 515B 465B 446B 813B 54,894B 851B 5,496B 2,202B 26,325B 2,242B 2,194B 94,149B | EV / Sales 2026 * |
5.94x | EV / Sales 2027 * | 5.52x |
| Free-Float |
77.08% | Yield 2026 * |
2.2% | Yield 2027 * | 2.33% |
Last Transcript: Johnson & Johnson
| 1 day | +0.32% | ||
| 1 week | -3.23% | ||
| Current month | -3.23% | ||
| 1 month | +0.17% | ||
| 3 months | +19.05% | ||
| 6 months | +34.73% | ||
| Current year | +16.16% |
| 1 week | 235.43 |  | 251.71 |
| 1 month | 235.43 | | 251.71 |
| Current year | 200.91 | | 251.71 |
| 1 year | 141.5 | | 251.71 |
| 3 years | 140.68 | | 251.71 |
| 5 years | 140.68 | | 251.71 |
| 10 years | 106.07 | | 251.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 63 | 02/01/2022 |
Joseph Wolk
DFI | Director of Finance/CFO | 59 | 30/06/2018 |
Penny M. Heaton
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Anne Mulcahy
BRD | Director/Board Member | 72 | 22/10/2009 |
Mark McClellan
BRD | Director/Board Member | 62 | 14/10/2013 |
Mary Beckerle
BRD | Director/Board Member | 71 | 08/06/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.83% | 14.01% | 253 M€ | |
| -1.01% | 12.91% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.32% | -3.23% | +44.22% | +56.01% | 579B | |
| +0.72% | -5.86% | +13.89% | +218.81% | 885B | |
| -0.96% | -0.85% | +7.38% | +50.47% | 407B | |
| -2.93% | -7.03% | +11.14% | +27.55% | 350B | |
| -1.25% | -5.55% | +22.14% | +55.83% | 302B | |
| -1.85% | -6.70% | +20.11% | +33.64% | 301B | |
| -0.24% | -6.49% | +22.33% | +4.06% | 286B | |
| +0.53% | -4.80% | +13.75% | +61.56% | 199B | |
| -0.83% | -3.37% | +22.59% | +79.29% | 179B | |
| -0.30% | +4.20% | -58.52% | -51.19% | 171B | |
| Average | -0.68% | -3.80% | +11.90% | +53.60% | 365.97B | |
| Weighted average by Cap. | -0.46% | -4.18% | +16.59% | +82.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101B 86.75B 78.31B 75.14B 137B 9,247B 143B 926B 371B 4,434B 378B 370B 15,859B | 106B 91.5B 82.6B 79.26B 145B 9,753B 151B 976B 391B 4,677B 398B 390B 16,727B |
| Net income | 23.64B 20.38B 18.4B 17.65B 32.19B 2,172B 33.69B 217B 87.12B 1,042B 88.71B 86.81B 3,725B | 25.2B 21.73B 19.61B 18.82B 34.32B 2,316B 35.91B 232B 92.88B 1,111B 94.57B 92.56B 3,972B |
| Net Debt | 17.99B 15.51B 14B 13.43B 24.49B 1,653B 25.63B 165B 66.3B 793B 67.51B 66.07B 2,835B | 6.06B 5.23B 4.72B 4.53B 8.25B 557B 8.64B 55.76B 22.34B 267B 22.75B 22.26B 955B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 240.40 $ | +0.32% | 7,179,790 |
| 05/03/26 | 239.63 $ | -2.31% | 9,375,412 |
| 04/03/26 | 245.30 $ | -0.59% | 5,767,980 |
| 03/03/26 | 246.75 $ | -0.73% | 6,178,739 |
| 02/03/26 | 248.56 $ | +0.05% | 9,042,359 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition